Safety Events of Interest with the De Novo Use of Everolimus in Heart Transplant Recipients: 24-Month Analysis of the A2310 Study

被引:0
|
作者
Lehmkuhl, H.
Hirt, S.
Rinaldi, M.
Bara, C.
Zuckermann, A.
Lopez, P.
Cines, M.
Dong, G.
Keogh, A.
机构
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
163
引用
收藏
页码:74 / 75
页数:2
相关论文
共 50 条
  • [1] Cardiovascular Events with De Novo Use of Everolimus in Heart Transplant Recipients: 24-Month Analysis of the A2310 Study
    Potena, L.
    Schultz, U.
    Bara, C.
    Arizon, J. M.
    Dong, G.
    Lopez, P.
    Epailly, E.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (04): : S26 - S26
  • [2] DE NOVO USE OF EVEROLIMUS IN HEART TRANSPLANT RECIPIENTS: CORRELATION BETWEEN LIPID LEVELS AND CARDIOVASCULAR EVENTS BASED ON THE 24 MONTH RESULTS OF A2310 STUDY
    Potena, Luciano
    Bara, Christoph
    Dong, Gaohong
    Lopez, Patricia
    Epailly, Eric
    [J]. TRANSPLANT INTERNATIONAL, 2015, 28 : 436 - 436
  • [3] Correlation Between Lipid Levels and Cardiovascular Events in Heart Transplant Recipients: 24-Month Analysis of the A2310 Study
    Potena, L.
    Bara, C.
    Dong, G.
    Lopez, P.
    Epailly, E.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (04): : S60 - S60
  • [4] 24-Month Safety and Efficacy of Concentration Controlled Everolimus with Reduced Cyclosporine Versus Mycophenolate Mofetil in 721 De Novo Heart Transplant Recipients: Results from the A2310 Study
    Epailly, E.
    Eisen, H.
    Pauly, D.
    Hirt, S.
    Lehmkuhl, H.
    Andreassen, A.
    Rinaldi, M.
    Yonan, N.
    Potena, L.
    Zuckermann, A.
    Dong, G.
    Panis, C.
    Lopez, P.
    Kobashigawa, J.
    [J]. TRANSPLANTATION, 2012, 94 (10) : 127 - 127
  • [5] Effect of Everolimus Based Immunosuppression on De Novo Heart Transplant Recipients-24 Months Efficacy and Safety Results from A2310 Study
    Kobashigawa, J.
    Pauly, D.
    Kfoury, A.
    Ross, H.
    Wang, S. -S.
    Cantin, B.
    van Bakel, A.
    Starling, R.
    Hirt, S.
    Dong, G.
    Panis, C.
    Lopez, P.
    Eisen, H.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 67 - 68
  • [6] ADVERSE EVENTS ASSOCIATED WITH mTOR INHIBITION: RESULTS FROM THE A2310 STUDY COMPARING EVEROLIMUS AND MMF IN DE NOVO HEART TRANSPLANT RECIPIENTS
    Poncelet, A.
    Musumeci, F.
    Fuchs, U.
    Mattei, M. F.
    Dong, G.
    Lopez, P.
    Hirt, S.
    [J]. TRANSPLANT INTERNATIONAL, 2011, 24 : 58 - 58
  • [7] CARDIOVASCULAR EVENTS WITH DE NOVO USE OF EVEROLIMUS IN HEART TRANSPLANT RECIPIENTS
    Potena, Luciano
    Schulz, Uwe
    Bara, Christoph
    Arizon Del Prado, Jose M.
    Balfour, Alison
    Kohler, Sven
    Lopez, Patricia M.
    Epailly, Eric
    [J]. TRANSPLANT INTERNATIONAL, 2013, 26 : 46 - 46
  • [8] EFFICACY AND SAFETY OF EVEROLIMUS WITH REDUCED-EXPOSURE CYCLOSPORINE IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS: 24-MONTH ANALYSIS FROM THE TRANSFORM STUDY
    Sommerer, Claudia
    Pinchuk, Aleksey
    Aleman, Silvina
    Vuiblet, Vincent
    Van der Giet
    Amante, Angel Joaquin
    Han, Duck Jong
    Huynh-Do, Uyen
    Ingsathit, Atiporn
    Gawai, Apurva
    Gutierrez, Maria Pilar Hernandez
    Carmellini, Mario
    [J]. TRANSPLANTATION, 2020, 104 (09) : S622 - S623
  • [9] Delayed Introduction of Everolimus Versus Tacrolimus in de Novo Liver Transplant Recipients: Safety Events of Interest with Everolimus Use
    Fischer, L.
    Chavin, K.
    Huang, M. A.
    Kozlowski, T.
    Dong, G.
    Lopez, P.
    Junge, G.
    De Carlis, L.
    [J]. TRANSPLANTATION, 2012, 94 (10) : 48 - 48
  • [10] Efficacy and Renal Function in De NOVO Heart Transplant Recipients Receiving Everolimus with Reduced CsA Compared to MMF with Standard CsA: The A2310 Study
    Eisen, H. J.
    Pauly, D.
    Starling, R.
    Kfoury, A.
    Ross, H.
    Wang, S.
    Cantin, B.
    Hirt, S.
    Lehmkuhl, H.
    Ewald, G.
    Van Bakel, A.
    Zuckermann, A.
    Lopez, P.
    Dong, G.
    Pains, C.
    Jiang, H.
    Cornu-Artis, C.
    Kobashigawa, J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 129 - 130